Blog
Daily evidence-led peptide research, regulatory news, expert digest and explainers. Every claim sourced; no AI tells.
Page 36
Is CJC-1295/ipamorelin flushing normal?
Facial flushing after CJC-1295 and ipamorelin injections is a known, documented reaction pattern for this peptide class, not an unusual one.
PNPHO nanocarrier for nasal semaglutide
A thermoresponsive PNPHO nanocarrier encapsulated semaglutide at 89% efficiency and improved glucose tolerance in animals. The research is preclinical.
PNPHO nanocarrier for nasal semaglutide
A thermoresponsive PNPHO nanocarrier encapsulated semaglutide at 89% efficiency and improved glucose tolerance in animals. The research is preclinical.
What is KLOW? The peptide blend, explained
KLOW mixes BPC-157, TB-500, GHK-Cu, and KPV. Here is what the evidence for each ingredient shows, and why none of it answers a fracture-healing question.
PT-141 for low libido on GLP-1 drugs
Reduced libido is a reported side effect on GLP-1 drugs. Here is what the evidence shows for PT-141 (bremelanotide) and kisspeptin as options for women.
Retatrutide and DKA in type 1 diabetes
A Cureus 2026 case report: a type 1 diabetes patient self-injected online-sourced retatrutide and developed impending DKA alongside a Shigella infection.
A nasal spray for semaglutide? Not yet
Sydney researchers built a needle-free nasal nanocarrier for semaglutide and tested it in cells and animals, not yet in people.
Semaglutide review: weight loss and CRP
A pooled review of nine trials found subcutaneous semaglutide cut body weight and C-reactive protein versus placebo in adults with overweight or obesity.
Semaglutide and CRP in obesity: 2026 data
A 2026 meta-analysis of nine trials found semaglutide cut body weight 12% and C-reactive protein 41% versus placebo in non-diabetic adults with obesity.
Semax for ADHD: evidence in young adults
Semax modulates BDNF and dopamine signalling in animal studies. It has no approved use for ADHD and no published safety data in adolescents or young adults.
Hair shedding after tirzepatide
Hair shedding after tirzepatide needs assessment, not an untested swap from minoxidil to GHK-Cu or KPV.
Needle reuse and vial contamination
A used needle can carry material into another vial. CDC injection-safety guidance explains why each vial entry needs new sterile equipment.